FDA issues safety signal on ALCL & breast implants
January 31, 2011
FDA issues safety signal on ALCL & breast implants | www.psnextra.org
http://www.psnextra.org/Articles/FDA-ACLC-Issue.htmlThere is a link between breast implants and anaplastic large cell lymphoma (ALCL). This very rare tumor has almost no cases in the literature. There appears that there might be an association between the two.
December 17, 2007
Ipsen and Medicis announce submission of Reloxin(R) in aesthetics to the FDA | www.pipelinereview.com
Lowering cost of Botox is key, but not enough to induce patients to undergo Botox treatments.
Reloxin Gives Allergan's Botox A Run for the Money!
December 13, 2007
Ipsen and Medicis announce submission of Reloxin(R) in aesthetics to the FDA | www.pipelinereview.com
For too long Allergan has monopolized the therapeutic and cosmetic market of botulinum toxin type A, and has taken full advantage of that monopoly by raising the price of Botox almost biannually. Reloxin studies are very favorable when compared to Botox, and may even surpass it in one or two aspects. There is a lesser protein load and therefore less antigenic than Botox and this may lead to a longer lasting effect. Studies already show and support this. In addition, there is a greater diffusion of the toxin from pontiff injection, and this is desirable in certain areas as the large frontalis areas of the face, and certainly in the large areas we tret for hyperhidrosis of the palms, soles and axillae, The conversion rate of units is not to be looked at as a chore of conversion, but as learning a new language. Don't look to convert units to units...just learn the required units of the new toxin. The shelf life appears to be slily longer as well. Cudos to Reloxin-watch out Botox!
August 28, 2007
New Medicare Regulations Adopted To Reduce Certain Hospital Infections And Medical Errors | www.medicalnewstoday.com
If a patient gets a bedsore, who pays for it? Most importantly, what does this mean to KCI and the other wound companies? Where will it end?
They have improved, but they are not the holy grail
July 30, 2007
Recurrence of Spider Angiomas After Laser Treatment | dermatology.jwatch.org
Lasers are better than they were 10 years ago. Especially for vascular lesions; however, they are not all purpose machines that can do everything, as evidenced by new ones every year.
July 12, 2007
Norwegian hacker says he can bypass AT&T on iPhone | today.reuters.com
It would be great to get an unlocked i-phone...
May 29, 2007
Getting a Discount on Plastic Surgery | online.wsj.com
Discount cosmetic surgery is already here, but not via large commercial companies. Retention of actual plastic and reconstructive surgeons may be difficult if they are not paying well. There is a place for this, however the solo practitioner will continue to have word of mouth and a place.
New Organiceuticals May Help Bring Back Beauty!
May 29, 2007
http://www.nytimes.com/2007/04/26/fashion/26skin.html?_r=1&ref=health&oref=slogin | www.nytimes.com
All that glitters is not gold...but some might be! Anti-oxidants are the promise of saving our "hides"!
May 28, 2007
FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
Keep Hydroquinones Around!
Non-Invasive Screening of the Skin
May 17, 2007
New tool allows noninvasive screening of skin lesions | www.modernmedicine.com
The company hopes to apply for European regulatory approval next year, with U.S. market approval and launch to follow. The current price of the device is 15,000 EUR. This device promises to be a remarkable time and money saver for medicine. Approximately 80-95% of lesions excised by dermatologists prove non-cancerous when examined histologically. This is wasted time, money and unnecessary anxiety for patients.
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011